PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, Vienna, Austria.\', \'Division of Clinical Virology, Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.\', \'Department of Pathology, Medical University of Vienna, Vienna, Austria.\', \'Department of Internal Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Vienna, Austria.\', \'Department of Internal Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, Vienna, Austria. zeljko.kikic@meduniwien.ac.at.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s00508-020-01776-w
?:doi
?:hasPublicationType
?:journal
  • Wiener klinische Wochenschrift
is ?:pmid of
?:pmid
?:pmid
  • 33289854
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.345
?:rankingScore_hIndex
  • 46
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19: IgG seroconversion under intensive glucocorticoid treatment in a high-risk patient with minimal change disease.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all